These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30760538)

  • 1. Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
    Barnabas GD; Bahar-Shany K; Sapoznik S; Helpman L; Kadan Y; Beiner M; Weitzner O; Arbib N; Korach J; Perri T; Katz G; Blecher A; Brandt B; Friedman E; Stockheim D; Jakobson-Setton A; Eitan R; Armon S; Brand H; Zadok O; Aviel-Ronen S; Harel M; Geiger T; Levanon K
    Mol Cell Proteomics; 2019 May; 18(5):865-875. PubMed ID: 30760538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
    Bahar-Shany K; Barnabas GD; Deutsch L; Deutsch N; Glick-Saar E; Dominissini D; Sapoznik S; Helpman L; Perri T; Blecher A; Katz G; Yagel I; Rosenblatt O; Shai D; Brandt B; Meyer R; Mohr-Sasson A; Volodarsky-Perel A; Zilberman I; Armon S; Jakobson-Setton A; Eitan R; Kadan Y; Beiner M; Josephy D; Brodsky M; Friedman E; Anafi L; Molchanov Y; Korach J; Geiger T; Levanon K
    Int J Cancer; 2023 Feb; 152(4):781-793. PubMed ID: 36214786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer.
    Cooper TT; Dieters-Castator DZ; Liu J; Siegers GM; Pink D; Veliz L; Lewis JD; Lagugné-Labarthet F; Fu Y; Steed H; Lajoie GA; Postovit LM
    J Ovarian Res; 2024 Jul; 17(1):149. PubMed ID: 39020428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.
    Hulstaert E; Levanon K; Morlion A; Van Aelst S; Christidis AA; Zamar R; Anckaert J; Verniers K; Bahar-Shany K; Sapoznik S; Vandesompele J; Mestdagh P
    Neoplasia; 2022 Feb; 24(2):155-164. PubMed ID: 34998206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I
    BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study.
    Maritschnegg E; Heitz F; Pecha N; Bouda J; Trillsch F; Grimm C; Vanderstichele A; Agreiter C; Harter P; Obermayr E; Vergote I; Zeillinger R; Speiser P
    Int J Gynecol Cancer; 2018 Nov; 28(9):1692-1698. PubMed ID: 30376484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2.
    Marcišauskas S; Ulfenborg B; Kristjansdottir B; Waldemarson S; Sundfeldt K
    J Proteomics; 2019 Mar; 196():57-68. PubMed ID: 30710757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data mining techniques for cancer detection using serum proteomic profiling.
    Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
    Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
    Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
    BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling in ovarian cancer.
    Kim G; Minig L; Kohn EC
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
    Xiao Y; Bi M; Guo H; Li M
    EBioMedicine; 2022 May; 79():104001. PubMed ID: 35439677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
    Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
    Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
    Zheng X; Li X; Wang X
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
    Ryu J; Thomas SN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of biomarkers for the ovarian cancer diagnosis.
    Zhang B; Cai FF; Zhong XY
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
    Zhang W; Ou X; Wu X
    Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.